HOLX · As filed with the SEC

Hologic cash flow statement, by quarter

The statement as Hologic presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.

Consolidated Statements of Cash Flows · USD

USD	Q1 FY26 3 months ended Dec 27, 2025	Q4 FY25^† 3 months ended Sep 27, 2025	Q3 FY25^† 3 months ended Jun 28, 2025	Q2 FY25^† 3 months ended Mar 29, 2025	Q1 FY25 3 months ended Dec 28, 2024	Q4 FY24^† 3 months ended Sep 28, 2024	Q3 FY24^† 3 months ended Jun 29, 2024	Q2 FY24^† 3 months ended Mar 30, 2024
OPERATING ACTIVITIES
Net income	179,100,000	—	194,900,000^†	(17,400,000)^†	201,000,000	—	194,500,000^†	169,900,000^†
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation	26,300,000	35,400,000^†	26,100,000^†	24,100,000^†	23,300,000	24,100,000^†	22,600,000^†	23,000,000^†
Amortization of acquired intangible assets	43,300,000	44,100,000^†	44,000,000^†	52,100,000^†	50,700,000	50,500,000^†	49,700,000^†	50,700,000^†
Stock-based compensation expense	26,900,000	12,300,000^†	13,500,000^†	28,400,000^†	30,100,000	13,200,000^†	14,600,000^†	25,800,000^†
Deferred income taxes	(1,100,000)	(30,300,000)^†	(29,100,000)^†	(62,700,000)^†	(19,500,000)	(19,800,000)^†	(5,500,000)^†	(29,200,000)^†
Intangible asset and equipment impairment charges	—	—	—	—	—	—	13,700,000^†	26,800,000^†
Intangible asset impairment charges	—	—	0^†	220,900,000^†	0	—	13,700,000^†	26,800,000^†
Contingent consideration fair value adjustments	—	—	—	—	—	0^†	0^†	—
Other adjustments and non-cash items	6,600,000	28,400,000^†	13,700,000^†	20,400,000^†	(19,100,000)	11,800,000^†	7,700,000^†	(4,500,000)^†
Changes in operating assets and liabilities:
Accounts receivable	18,000,000	4,600,000^†	48,600,000^†	(3,700,000)^†	(41,700,000)	43,500,000^†	17,600,000^†	18,100,000^†
Inventories	(8,600,000)	33,400,000^†	7,100,000^†	(5,700,000)^†	(36,100,000)	(300,000)^†	(16,700,000)^†	(17,400,000)^†
Prepaid income taxes	3,200,000	21,800,000^†	5,500,000^†	(36,400,000)^†	29,200,000	52,200,000^†	41,400,000^†	(45,200,000)^†
Prepaid expenses and other assets	(25,100,000)	(4,800,000)^†	7,900,000^†	(4,400,000)^†	13,200,000	11,500,000^†	8,300,000^†	(15,100,000)^†
Accounts payable	7,800,000	1,100,000^†	(17,600,000)^†	(31,000,000)^†	36,200,000	(4,300,000)^†	(200,000)^†	19,500,000^†
Accrued expenses and other liabilities	(17,300,000)	29,100,000^†	32,300,000^†	(39,100,000)^†	(54,600,000)	14,900,000^†	45,200,000^†	49,000,000^†
Deferred revenue	(29,200,000)	(12,200,000)^†	(3,600,000)^†	23,900,000^†	(23,400,000)	(10,600,000)^†	11,200,000^†	19,300,000^†
Net cash provided by operating activities	229,900,000	355,100,000^†	343,300,000^†	169,400,000^†	189,300,000	367,000,000^†	405,800,000^†	292,400,000^†
INVESTING ACTIVITIES
Acquisition of businesses, net of cash acquired	—	0^†	1,300,000^†	(322,500,000)^†	(300,000)	(297,300,000)^†	0^†	0^†
Sale of business, net of cash disposed	—	0^†	0^†	0^†	0	0^†	0^†	0^†
Capital expenditures	—	—	—	—	—	—	—	(12,800,000)^†
Capital expenditures	(14,700,000)	(13,700,000)^†	(12,800,000)^†	(15,500,000)^†	(16,800,000)	(16,400,000)^†	(20,500,000)^†	(12,800,000)^†
Proceeds from the Department of Defense	—	—	—	—	—	0^†	0^†	—
Increase in equipment under customer usage agreements	(20,400,000)	(16,700,000)^†	(22,000,000)^†	(24,700,000)^†	(14,800,000)	(13,900,000)^†	(13,400,000)^†	(15,200,000)^†
Strategic investments	24,000,000	(68,000,000)^†	18,000,000^†	9,000,000^†	6,000,000	(85,000,000)^†	3,000,000^†	5,000,000^†
Purchase of intellectual property	0	0^†	0^†	0^†	(15,400,000)	0^†	(10,000,000)^†	0^†
Maturities of available-for-sale securities	48,000,000	48,000,000^†	48,000,000^†	48,000,000^†	32,000,000	0^†	0^†	0^†
Other activity	(1,000,000)	(800,000)^†	(800,000)^†	(300,000)^†	(700,000)	(400,000)^†	4,300,000^†	(5,500,000)^†
Net cash used in investing activities	(12,100,000)	(132,100,000)^†	(4,300,000)^†	(324,300,000)^†	(22,000,000)	(595,700,000)^†	(42,600,000)^†	(38,500,000)^†
FINANCING ACTIVITIES
Payment of contingent consideration	—	(2,200,000)^†	1,100,000^†	—	—	(5,200,000)^†	(5,200,000)^†	—
Payment of deferred acquisition consideration	—	—	—	—	—	—	0^†	0^†
Repayment of long-term debt	0	—	(9,300,000)^†	(9,400,000)^†	(9,400,000)	—	(9,300,000)^†	(9,400,000)^†
Repurchases of common stock	0	0^†	(35,600,000)^†	(200,000,000)^†	(517,300,000)	(58,300,000)^†	(100,000,000)^†	0^†
Proceeds under employee stock plans	8,300,000	11,100,000^†	6,800,000^†	8,700,000^†	12,200,000	12,600,000^†	6,800,000^†	8,900,000^†
Payment of minimum tax withholdings on net share settlements of equity awards	(18,100,000)	(200,000)^†	(100,000)^†	(200,000)^†	(21,700,000)	(800,000)^†	(300,000)^†	(100,000)^†
Payments under finance lease obligations	(900,000)	(900,000)^†	(800,000)^†	(800,000)^†	(800,000)	(900,000)^†	(1,000,000)^†	(1,000,000)^†
Net cash used in financing activities	(10,700,000)	1,600,000^†	(40,100,000)^†	(201,700,000)^†	(537,000,000)	(56,800,000)^†	(103,800,000)^†	(4,200,000)^†
Effect of exchange rate changes on cash and cash equivalents	1,400,000	(300,000)^†	6,800,000^†	4,000,000^†	(8,400,000)	6,600,000^†	(300,000)^†	(1,800,000)^†
Net increase (decrease) in cash and cash equivalents	208,500,000	224,300,000^†	305,700,000^†	(352,600,000)^†	(378,100,000)	(278,900,000)^†	259,100,000^†	247,900,000^†
Cash and cash equivalents, beginning of period	1,959,500,000	1,735,200,000	1,429,500,000	1,782,100,000	2,160,200,000	2,439,100,000	2,180,000,000	1,932,100,000
Cash and cash equivalents, end of period	2,168,000,000	1,959,500,000	1,735,200,000	1,429,500,000	1,782,100,000	2,160,200,000	2,439,100,000	2,180,000,000

† Derived: worked out from the filings, not stated in them. A fourth quarter is the 10-K year less the nine months in the third-quarter 10-Q; a quarter of cash flows is year to date less the prior year to date.

As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.